Jimi Olaghere Opens up About His Sickle Cell Disease and CRISPR Trial
Jimi has dealt with sickle cell disease, a genetic disorder with serious implications, his entire life. Undergoing a CRISPR gene editing trial turned his hope for a cure into reality with promising re...
5 Mai 202239min
TJ Cradick Speaks About Their HIV CRISPR Therapy in Trials
TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.
31 Mar 202223min
Bryce Olson Relays His Experience on Personalized Therapies for Cancer Patients
After being diagnosed with aggressive prostate cancer, Bryce Olson quickly learned the science behind it and has leveraged NGS to understand his tumor genomics and find opportunities in personalized t...
15 Mar 202242min
Neville Sanjana Discusses Ways to Enhance CRISPR-Cas13 Knockdown in Human Cells
In this collaboration episode with NEB, we interview Dr. Neville Sanjana, a core faculty member at the New York Genome Center, about his recent publication in which chemically modified guide RNAs were...
28 Jan 202232min
Kiana Aran Chats About her Nature Award and New Non-Profit
In this episode, we chat with Dr. Kiana Aran, the CSO of Cardea Bio and associate professor at Keck Graduate Institute, who recently won the Nature Research Award for Inspiring Women in Science. Dr. A...
15 Nov 202141min
6 Women CRISPR Leaders Get Candid About Their Journeys to the Top
We chatted with six female leaders in the CRISPR—Alison van Eenennaam, Ph.D., Kiana Aran, Christina Trojel-Hansen, Ph.D., Laura Lambert, Ph.D., Elena Miñones Moyano, Ph.D., and Samantha Maragh, Ph.D.—...
28 Okt 20211h 2min
Jesse Boehm Discusses Tackling Rare Cancers Using CRISPR
In this CRISPR Cuts episode, Dr. Jesse Boehm, the Chief Scientific Officer of the Break Through Cancer Foundation and principal investigator at the Broad Institute, talks about his work on rare cancer...
28 Jul 202130min
NIH Scientists Discuss the iNDI Project for Alzheimer's Disease Modeling
The Inducible Pluripotent Stem Cell Neurodegeneration Initiative (iNDI), an NIH effort, aims to standardize disease models for Alzheimer’s and related dementias. Hear the principal contributors, Dr. M...
14 Jun 202137min
